Qlif-26. assessing the relationship between vincristine use and outcomes in a retrospective cohort of pediatric patients with average risk medulloblastomas

CONCLUSION:Vincristine was omitted or the dose was reduced in the majority of patients. Incomplete vincristine use was not found to be associated with OS or EFS.

Source: Neuro-Oncology - November 6, 2016 Category: Cancer & Oncology Authors: Liu, D., Fischer, C., Petriccione, M., Goldman, D., Riedel, E., Braganca, K. D. Tags: QUALITY OF LIFE Source Type: research